Mycophenolate mofetil immunosuppressive therapies increase the incidence of cytomegalovirus infection in renal transplantation

Transplantation Proceedings

Volumn 34, Issue 1, 2002, Pages 97-

  Munoz M A ^a   Andres A ^a   Gallego, R ^a   Morales, E ^a   Morales, J M ^a   Aguado, J M ^a   Lumbreras, C ^a   Torres, A ^a   Rodicio, J L ^a   Praga, M ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SEROLOGY;

ADULT; AGE FACTORS; ANTIGENS, VIRAL; ANTILYMPHOCYTE SERUM; CYTOMEGALOVIRUS INFECTIONS; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY TRANSPLANTATION; MIDDLE AGED; MUROMONAB-CD3; MYCOPHENOLIC ACID; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TISSUE DONORS;

EID: 0036224139     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(01)02683-5     Document Type: Article

References (4)